UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$438M |
| 2 |
Lockheed Martin
LMT
|
+$402M |
| 3 |
TAL Education Group
TAL
|
+$294M |
| 4 |
Microsoft
MSFT
|
+$269M |
| 5 |
Wells Fargo
WFC
|
+$235M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Mastercard
MA
|
+$384M |
| 2 |
Adobe
ADBE
|
+$372M |
| 3 |
Veeva Systems
VEEV
|
+$342M |
| 4 |
Thermo Fisher Scientific
TMO
|
+$289M |
| 5 |
Global Payments
GPN
|
+$287M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.1% |
| 2 | Consumer Discretionary | 13.57% |
| 3 | Healthcare | 12.46% |
| 4 | Financials | 11.55% |
| 5 | Communication Services | 9.78% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1976
Ameresco
AMRC
$1.33B
| $928K | ﹤0.01% |
17,761
-300
| -2% | -$12.9K |
|
1977
Quanterix
QTRX
$112M
| $924K | ﹤0.01% |
19,876
-282
| -1% | -$12.3K |
|
1978
Stoneridge
SRI
$202M
| $923K | ﹤0.01% |
30,547
| – | – |
|
|
TBI
1979
Trueblue
TBI
$317M
| $922K | ﹤0.01% |
49,346
| – | – |
|
1980
Standex International
SXI
$4.02B
| $921K | ﹤0.01% |
11,885
+2,388
| +25% | +$170K |
|
1981
Chefs' Warehouse
CHEF
$4.46B
| $917K | ﹤0.01% |
35,681
+3,115
| +10% | +$61.3K |
|
|
HEES
1982
DELISTED
H&E Equipment Services
HEES
| $916K | ﹤0.01% |
30,712
| – | – |
|
1983
Matthews International
MATW
$711M
| $912K | ﹤0.01% |
31,005
| – | – |
|
1984
Pathward Financial
CASH
$1.79B
| $911K | ﹤0.01% |
24,930
-5,390
| -18% | -$164K |
|
1985
Dine Brands
DIN
$442M
| $911K | ﹤0.01% |
15,705
+876
| +6% | +$53.3K |
|
|
1986
Wells Fargo 7.5% Non Cumv Perp Conv
WFC.PRL
$4.65B
| – | – |
0
| – | – |
|
1987
Vericel Corp
VCEL
$2.28B
| $910K | ﹤0.01% |
29,479
-8,800
| -23% | -$209K |
|
|
EXK
1988
Endeavour Silver
EXK
$3B
| $909K | ﹤0.01% |
180,091
+35,800
| +25% | +$132K |
|
|
HNGR
1989
DELISTED
Hanger Inc.
HNGR
| $908K | ﹤0.01% |
41,296
| – | – |
|
|
VIVO
1990
DELISTED
Meridian Bioscience Inc
VIVO
| $906K | ﹤0.01% |
48,462
-2,210
| -4% | -$41.3K |
|
|
TVRD
1991
Tvardi Therapeutics
TVRD
$22M
| $901K | ﹤0.01% |
1,655
| – | – |
|
|
ATRI
1992
DELISTED
Atrion Corp
ATRI
| $897K | ﹤0.01% |
1,397
-5
| -0.4% | -$3.11K |
|
1993
Archrock
AROC
$5.81B
| $893K | ﹤0.01% |
103,147
-5,899
| -5% | -$43.1K |
|
1994
United Natural Foods
UNFI
$2.8B
| $891K | ﹤0.01% |
55,778
-4,481
| -7% | -$75K |
|
|
WIRE
1995
DELISTED
Encore Wire Corp
WIRE
| $888K | ﹤0.01% |
14,661
| – | – |
|
1996
Compugen
CGEN
$220M
| $886K | ﹤0.01% |
73,150
-3,300
| -4% | -$45.5K |
|
1997
Brown-Forman Class A
BF.A
$13.1B
| $886K | ﹤0.01% |
12,057
+5,243
| +77% | +$377K |
|
|
NP
1998
DELISTED
Neenah, Inc. Common Stock
NP
| $886K | ﹤0.01% |
16,010
+4,036
| +34% | +$185K |
|
|
NXGN
1999
DELISTED
NextGen Healthcare, Inc. Common Stock
NXGN
| $884K | ﹤0.01% |
48,477
+8,400
| +21% | +$133K |
|
2000
Simulations Plus
SLP
$371M
| $883K | ﹤0.01% |
12,280
+600
| +5% | +$39.8K |
|
Similar funds
UBS AM's Q4 2020 Portfolio in Review
As of Q4 2020, UBS AM held 2,632 positions worth $213B, up 15% from $186B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
UBS AM's Q4 2020 filing shows 139 new, 1,393 increased, 625 reduced and 83 closed positions. Its largest new stake was Maravai LifeSciences: 3,763,012 shares worth $106M. The largest sale was Mastercard, an estimated $384M.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 24% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- UBS AM's largest Q4 2020 buy was Maravai LifeSciences: 3,763,012 shares worth $106M.
- UBS AM added most to Apple in Q4 2020, an estimated $438M increase.
- UBS AM's biggest Q4 2020 reduction was Mastercard, cutting an estimated $384M.
- UBS AM fully exited State Street Technology Select Sector SPDR ETF in Q4 2020, selling an estimated $115M.
- UBS AM's ten largest holdings make up 23% of its $213B portfolio in Q4 2020.
- UBS AM opened 139 new positions and closed 83 in Q4 2020.
- UBS AM's portfolio value rose 15% quarter-over-quarter to $213B.
Based on UBS AM's 13F filing for Q4 2020, filed 17 Feb 2021.